Protalix BioTherapeutics
PLX
PLX
25 hedge funds and large institutions have $18.4M invested in Protalix BioTherapeutics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
11% less funds holding
Funds holding: 28 → 25 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
25
Holding in Top 10
–
Calls
$658K
Puts
$93K
Top Buyers
| 1 | +$185K | |
| 2 | +$173K | |
| 3 | +$148K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$60.6K |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$58.9K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$502K | |
| 3 | -$222K | |
| 4 |
Renaissance Technologies
New York
|
-$155K |
| 5 |
Walleye Trading
New York
|
-$140K |